Table 6.

Correlation between GLP-1 agonist dose and change in clinical parameters.

	n	r	p-Value
ΔBMI	66	−0.146	0.241
ΔChol	59	−0.228	0.083
ΔTG	59	−0.119	0.371
ΔHDL	22	0.104	0.645
ΔLDL	48	−0.326	0.024
ΔVLDL	59	−0.12	0.367
ΔALT	46	0.224	0.134
ΔAST	46	−0.014	0.927
ΔHbA1C	60	0.083	0.529
Δhs-CRP	7	0.267	0.562

Bold and underlined values indicate statistical significance.